Genomic characteristics of homologous recombination deficiency in ovarian cancer.

被引：0

作者：

Ma, Xiaoxue ^{[1
]}

Li, Mingwei ^{[1
]}

Lou, Feng ^{[1
]}

Cao, Shanbo ^{[1
]}

Wang, Huina ^{[1
]}

机构：

[1] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e17575

引用

页码：E17575 / E17575

页数：1

共 50 条

[21] Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort Validation of Decentralized Genomic Profiling
Denkert, Carsten
Romey, Marcel
Swedlund, Brad
Hattesohl, Akira
Teply-Szymanski, Julia
Kommoss, Stefan
Kaiser, Kristin
Staebler, Annette
du Bois, Andreas
Grass, Albert
Knappmeyer, Christiane
Heitz, Florian
Solimeno, Cara
Ebel, Thomas
Harter, Philipp
Marme, Frederik
Jank, Paul
Gaiser, Timo
Neff, Chris
Wagner, Uwe
Timms, Kirsten M.
Rodepeter, Fiona
JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (12): : 1254 - 1263
[22] High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer
Pfarr, Nicole
von Schwarzenberg, Karin
Zocholl, Dario
Merkelbach-Bruse, Sabine
Siemanowski, Janna
Mayr, Eva-Maria
Herold, Sylvia
Kleo, Karsten
Heukamp, Lukas C.
Willing, Eva-Maria
Menzel, Michael
Lehmann, Ulrich
Bartels, Stephan
Chakraborty, Shounak
Baretton, Gustavo
Demes, Melanie C.
Doering, Claudia
Kazdal, Daniel
Budczies, Jan
Rad, Roland
Wild, Peter
Christinat, Yann
Mckee, Thomas
Schirmacher, Peter
Horst, David
Buettner, Reinhard
Stenzinger, Albrecht
Sehouli, Jalid
Vollbrecht, Claudia
Hummel, Michael
Braicu, Elena I.
Weichert, Wilko
JCO PRECISION ONCOLOGY, 2024, 8
[23] Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
Watkins, Johnathan A.
Irshad, Sheeba
Grigoriadis, Anita
Tutt, Andrew N. J.
BREAST CANCER RESEARCH, 2014, 16 (03):
[24] Clinical-genomic characteristics of homologous recombination deficiency (HRD) in breast cancer: application model for practice
Du, Jinsui
Zhu, Lizhe
Duan, Chenglong
Ma, Nan
Zhou, Yudong
Li, Danni
Zhang, Jianing
Zhang, Jiaqi
Wang, Yalong
Liu, Xi
Ren, Yu
Wang, Bin
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
[25] Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
Johnathan A Watkins
Sheeba Irshad
Anita Grigoriadis
Andrew NJ Tutt
Breast Cancer Research, 16
[26] Homologous recombination deficiency and molecular subtype are associated with immunogenicity in ovarian cancer
Fares, Charlene M.
Fenerty, Kathleen E.
Chander, Cinthiya
Theisen, Matthew K.
Konecny, Gottfried E.
BIOMARKERS IN MEDICINE, 2022, 16 (10) : 771 - 782
[27] Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
da Cunha Colombo Bonadio, Renata Rodrigues
Fogace, Rodrigo Nogueira
Miranda, Vanessa Costa
Estevez Diz, Maria del Pilar
CLINICS, 2018, 73
[28] Homologous recombination deficiency testing in first-line ovarian cancer
Moore, K. N.
du Bois, A.
ANNALS OF ONCOLOGY, 2022, 33 (03) : 231 - 233
[29] Characterization of homologous recombination deficiency in uncommon epithelial ovarian cancer subtypes
How, J. A.
Timms, K. M.
Jazaeri, A. A.
Lu, K. H.
Yates, M. S.
GYNECOLOGIC ONCOLOGY, 2020, 159 : 90 - 90
[30] Detection of homologous recombination deficiency (HRD) using a novel genomic and epigenomic liquid biopsy assay in patients with breast cancer.
Barbacioru, Catalin
Yen, Jennifer
Tolkunov, Denis
Safabakhsh, Pegah
Wang, Hao
Gross, Andrew
Overstreet, Brooke
Jenkins, Colby
Drusbosky, Leylah
Kiedrowski, Lesli Ann
Eagle, Craig
Chuang, Han-Yu
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 2 3 4 5 →